Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Hims & Hers Health, Inc. (HIMS : NYSE)
 
 • Company Description   
Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco.

Number of Employees: 181

 
 • Price / Volume Information   
Yesterday's Closing Price: $11.12 Daily Weekly Monthly
20 Day Moving Average: 1,732,588 shares
Shares Outstanding: 191.80 (millions)
Market Capitalization: $2,132.84 (millions)
Beta: -0.11
52 Week High: $25.40
52 Week Low: $8.09
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -10.25% -11.22%
12 Week -15.95% -21.28%
Year To Date -23.84% -32.56%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
2269 CHESTNUT STREET SUITE 523
-
SAN FRANCISCO,CA 94123
USA
ph: 415-851-0195
fax: -
hims-ir@westwicke.com http://www.forhims.com
 
 • General Corporate Information   
Officers
Andrew Dudum - Chief Executive Officer and Chairman
Melissa Baird - Chief Operating Officer
Spencer Lee - Chief Financial Officer
Alex Bard - Director
Ambar Bhattacharyya - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MEDICAL INFO SYS
Sector: Medical
CUSIP: 433000106
SIC: 8011
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/21
Next Expected EPS Date: 08/16/21
Share - Related Items
Shares Outstanding: 191.80
Most Recent Split Date: (:1)
Beta: -0.11
Market Capitalization: $2,132.84 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.13 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.65 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/16/21  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 7.28
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -100.00%
Sales Growth
vs. Year Ago Period: 74.01%
vs. Previous Quarter: 26.16%
ROE
03/31/21 - -36.18
12/31/20 - -272.12
09/30/20 - -
ROA
03/31/21 - -11.55
12/31/20 - -6.61
09/30/20 - -
Current Ratio
03/31/21 - 17.29
12/31/20 - 0.23
09/30/20 - 0.44
Quick Ratio
03/31/21 - 17.06
12/31/20 - 0.23
09/30/20 - 0.44
Operating Margin
03/31/21 - -
12/31/20 - -
09/30/20 - -
Net Margin
03/31/21 - -
12/31/20 - -
09/30/20 - -
Pre-Tax Margin
03/31/21 - -91.26
12/31/20 - -
09/30/20 - -
Book Value
03/31/21 - 1.53
12/31/20 - 0.79
09/30/20 - 0.20
Inventory Turnover
03/31/21 - 2.32
12/31/20 - -
09/30/20 - -
Debt-to-Equity
03/31/21 - 0.00
12/31/20 - 0.00
09/30/20 - 0.00
Debt-to-Capital
03/31/21 - 0.00
12/31/20 - 0.00
09/30/20 - 0.00
 

Powered by Zacks Investment Research ©